Germany Continuous Glucose Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Product (Sensors, Transmitters, and Receivers), By End-User (Hospitals, Specialty Diabetes Clinics, Home Care, and Research & Manufacturing), and Germany Continuous Glucose Monitoring Market Insights, Industry Trend, Forecasts to 2035.

Germany Continuous Glucose Monitoring Market Insights Forecasts to 2035

• The Germany Continuous Glucose Monitoring Market Size was estimated at USD 1.1 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.46% from 2025 to 2035
• The Germany Continuous Glucose Monitoring Market Size is Expected to Reach USD 2.19 Billion by 2035

According to a research report published by Spherical Insights & Consulting, The Germany continuous Glucose Monitoring Market Size is Anticipated to reach USD 2.19 Billion By 2035, Growing at a CAGR of 6.46% from 2025 to 2035.  The Germany continuous glucose monitoring market is driven by the increasing diabetes incidence and the consequent necessity for effective management techniques. As part of a trend towards preventive healthcare, the German government has been actively sponsoring efforts to improve diabetes care

Market Overview

The Germany continuous glucose monitoring market is the business of designing, producing, and selling devices to allow real-time monitoring of glucose levels in people, especially those with diabetes. The devices usually comprise a thin sensor inserted under the skin, a data-transmitting transmitter, and a receiver or compatible smartphone upon which are displayed glucose values. The need for effective diabetes control solutions, including Continuous Glucose Monitoring (CGM) systems. Furthermore, recent technological developments in CGM have enhanced precision, sensor longevity, and ease of use, increasing the accessibility and attractiveness of CGM systems to healthcare providers and patients. Moreover, the coupling of CGM devices with mobile apps and insulin pumps has maximized diabetes care. The German Ministry of Health has approved various CGM systems for reimbursement, proving their effectiveness and safety. Additionally, the German Diabetes Center has been continuously working to raise awareness for diabetes and the advantages of CGM systems through advocacy groups and educational programs. This has facilitated greater patient involvement and a stronger commitment to embracing innovative monitoring technologies, encouraging active diabetes management.

Report Coverage

This research report categorizes the market for Germany continuous glucose monitoring market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany continuous glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany continuous glucose monitoring market.

Driving Factors

The market for continuous glucose monitoring (CGM) is spurred by increasing diabetes prevalence and demand for non-invasive, real-time glucose monitoring. Technological innovations like smartphone connectivity, longer sensor life, and cloud-based data storage increase convenience and precision for the end-user. Expanded use of personalized and preventive care facilitates increased adoption of CGM devices. Additionally, positive reimbursement policies and increasing awareness among non-diabetic health-conscious consumers and sportspersons are driving market growth.

Restraining Factors

Germany's health insurance packages can fail to reimburse costs for CGM devices comprehensively, as reimbursement rules by the Federal Joint Committee (G-BA) can leave some patient groups out. This translates to out-of-pocket expenses for individuals who do not qualify, and this sheds light on

Market Segmentation

The Germany continuous glucose monitoring market share is classified into product and end-user.

• The sensors segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

The Germany continuous glucose monitoring market is segmented by product into sensors, transmitters, and receivers. Among these, the sensors segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growth is driven by their critical function in glucose monitoring, high frequency of replacement, and growing use of combined CGM systems. Furthermore, their direct exposure to interstitial fluid and requirement for periodic replacement (every 7-14 days) generates persistent demand.

• The home care segment accounted for the highest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The Germany continuous glucose monitoring market is segmented by end-user into hospitals, specialty diabetes clinics, home care, and research & manufacturing. Among these, the home care segment accounted for the highest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is due to growing demand for self-monitoring by patients, growing personal use of CGM devices, and increasing focus on remote patient monitoring solutions.  Moreover, the ease of carrying out glucose monitoring solutions from home and the trend towards telehealth services have further cemented leadership for this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany continuous glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Dexcom, Inc.
• Abbott Laboratories
• Medtronic
• Roche Diagnostics
• Senseonics Holdings
• Ypsomed
• Others

Recent Developments:

• In October 2022, DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced that the Dexcom G7 Continuous Glucose Monitoring (CGM) System was made available for people with diabetes aged two years and older in the UK, Ireland, Germany, Austria, and Hong Kong – marking the first major milestone in the availability of the revolutionary new technology.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany continuous glucose monitoring market based on the below-mentioned segments

Germany Continuous Glucose Monitoring Market, By Product

• Sensors
• Transmitters
• Receivers

Germany Continuous Glucose Monitoring Market, By End-User

• Hospitals
• Specialty Diabetes Clinics
• Home Care
• Research & Manufacturing